Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRACLEER for Pulmonary arterial hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,472 adverse event reports in the FDA FAERS database where TRACLEER was used for Pulmonary arterial hypertension.

Most Reported Side Effects for TRACLEER

Side Effect Reports % Deaths Hosp.
Death 382 20.5% 382 85
Dyspnoea 229 12.3% 64 201
Pulmonary arterial hypertension 127 6.8% 85 70
Pneumonia 121 6.5% 41 109
Condition aggravated 86 4.6% 46 55
Fall 79 4.2% 16 65
Fluid retention 65 3.5% 20 60
Dizziness 63 3.4% 10 57
Cardiac failure congestive 60 3.2% 23 48
Aspartate aminotransferase increased 59 3.2% 8 35
Fatigue 59 3.2% 10 50
Alanine aminotransferase increased 57 3.1% 8 33
Malaise 57 3.1% 16 49
Disease progression 54 2.9% 47 21
Syncope 54 2.9% 11 48

Other Indications for TRACLEER

Pulmonary hypertension (116) Cor pulmonale chronic (101) Product used for unknown indication (86) Skin ulcer (14) Scleroderma associated digital ulcer (8) Systemic lupus erythematosus (6) Connective tissue disorder (5) Scleroderma (5) Systemic sclerosis (5)

Other Drugs Used for Pulmonary arterial hypertension

TREPROSTINIL (72,609) MACITENTAN (29,246) AMBRISENTAN (27,852) BOSENTAN (12,387) SELEXIPAG (11,861) RIOCIGUAT (9,158) EPOPROSTENOL (8,508) TADALAFIL (7,679) SILDENAFIL (5,239) ILOPROST (2,828)

Related Pages

TRACLEER Full Profile All Pulmonary arterial hypertension Drugs TRACLEER Demographics TRACLEER Timeline